TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01300949

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Spaeth/Richman Contrast Sensitivity Test
Description: internet based computerized contrast sensitivity test measuring central and peripheral vision using black and white stripes that decrease in contrast by fading to a white background.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Spaeth/Richman Contrast Sensitivity Test
Description: internet based computerized contrast sensitivity test measuring central and peripheral vision using black and white stripes that decrease in contrast by fading to a white background.
Study: NCT02716428

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TD-6450

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribavirin
Study: NCT01623583

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhanced Needle Phobia Intervention
Description: The enhanced intervention will include the standard intervention, with two enhancements:~* The video will include a segment with a patient using and discussing the analgesic effects of the Synera patch~* Before the intervention, a nurse will explain how Synera works and demonstrate its efficacy by having the patient apply it to the non-dominant forearm and leave it in place for 30 minutes, during the intervention. The patient will then be given the opportunity to gently poke 3 times an area of the forearm at least 3 inches from where the patch was applied, and then poke 3 times the center of the area where the patch was applied. The patient may repeat this process up to 3 times. The patient will be asked if he or she can feel the difference in sensitivity.
Study: NCT01300949

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Spaeth/Richman Contrast Sensitivity Test
Description: internet based computerized contrast sensitivity test measuring central and peripheral vision using black and white stripes that decrease in contrast by fading to a white background.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Pelli-Robson Contrast Sensitivity Chart
Description: wall chart contrast sensitivity test measuring central vision using black letters that decrease in contrast by fading to a white background.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Pelli-Robson Contrast Sensitivity Chart
Description: wall chart contrast sensitivity test measuring central vision using black letters that decrease in contrast by fading to a white background.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Pelli-Robson Contrast Sensitivity Chart
Description: wall chart contrast sensitivity test measuring central vision using black letters that decrease in contrast by fading to a white background.
Study: NCT01623583

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Needle Phobia Intervention
Description: The standard intervention will include the following components:~1. Educational material and discussion with the social worker about the benefits of AVF/AVG over catheter.~2. Basic training on relaxation breathing~3. Brief video of a patient overcoming needle phobia~4. Exposure to a cannulation needle while practicing relaxation breathing, ending in the patients physically holding the needle
Study: NCT03036696

Intervention type: OTHER
Intervention: Pregnant Mothers Interview
Description: Pregnant mothers will be interviewed and asked to provide feedback on common strategies used for recruitment, challenges that would preclude them from enrolling and participating in CRTs, their preferences for incentives, data collection, bio-specimen collection and preferences for methods related to non-invasive sample collection.~Data collection for pregnant mothers includes Clinical Health Update (3rd trimester) and Physical Activity questionnaires.~The following will be collected from mothers during the interview: self-reported behavioral data, maternal human milk (HM), stool, urine, saliva, and vaginal swab.

Intervention type: OTHER
Intervention: Breastfeeding Mothers Interview
Description: Breastfeeding mothers will be interviewed and asked to provide feedback on common strategies used for recruitment, challenges that would preclude them from enrolling and participating in CRTs, their preferences for incentives, data collection, bio-specimen collection, and preferences for methods related to non-invasive sample collection.~Data collection for breastfeeding mothers includes Clinical Health update (post-natal), Infant Feeding, and Physical Activity questionnaires.~The following will be collected from mothers during the interview: self-reported behavioral data, maternal human milk (HM), stool, urine, saliva, and vaginal swab.
Study: NCT01324908

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: extracorporeal photopheresis
Description: Undergo ECP

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study: NCT04026997

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CIN-102 Dose 1
Description: CIN-102 Dose 1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CIN-102 Dose 2
Description: CIN-102 Dose 2

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CIN-102 Dose 3
Description: CIN-102 Dose 3

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT01862874

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V501
Description: Formulated with aluminum hydroxyphosphate sulfate (AAHS) adjuvant

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Formulated with AAHS adjuvant
Study: NCT01475994

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Grass pollen : Dactylis glomerata
Description: The subjects will be challenged for 4 hours on two consecutive days (Day 1 and Day 2) with either 4000 pollen grains/m3 of dactylis glomerata pollen.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Challenge with clean air
Description: The subjects will be challenged for 4 hours on two consecutive days (Day 1 and Day 2) with clean air.
Study: NCT03072147

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Teriparatide
Description: 20 mcg of teriparatide injected in thigh or abdomen once a day for 24 weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 20 mcg of saline injected in thigh or abdomen once a day for 24 weeks.
Study: NCT01898962

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Complete Surgical Removal

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Radiosurgery
Study: NCT01595997

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DLX105
Description: intradermal injections (volume: 0.1 mL) of 0.02 mg (low dose cohort), 1 mg (high dose cohort) DLX105, days: Day 1, Day 4, Day 7 and Day 10

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: DLX105
Description: intradermal injections (volume: 0.1 mL) of 0.02 mg (low dose cohort), 1 mg (high dose cohort) DLX105, days: Day 1, Day 4, Day 7 and Day 10
Study: NCT01898962

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Ablative external beam radiation dose

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Subtotal surgical removal plus ablative radiation dose
Description: Residual tumor or close/positive margins should be followed by ablative radiation doses (by either stereotactic radiosurgery or convential EBRT) to constitute definitive locoregional treatment

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radioembolization
Description: radioembolization of the liver with Y-90 microspheres or other site-appropriate techniques
Study: NCT04260672

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Child Centred Health Dialog (CCHD)
Description: The universal part of CCHD means a structured dialogue between the nurse and the child in presence of its parents using eight illustrations based on the most important practices associated with overweight in preschool children: fruit and vegetables consumption, intake of sweetened beverages and portion size, physical activity, sedentary behaviour tooth brushing and sleep routines. The health dialog is completed by demonstrating the BMI-growth chart to show BMI development to give parents an accurate weight perception, identify overweight and support parental readiness towards a healthy lifestyle.~When the child is identified with an overweight or obesity, the entire family is invited to participate in the targeted part of CCHD: the Family Guidance, a family consultation based on the evidence based Standardized Obesity Family Therapy (Nowicka, 2011).
Study: NCT03150199

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Psychology + Motivational Interviewing
Description: Participants randomized to PP-MI will receive a treatment manual. For each session, a PP exercise will be described in the manual, with instruments and space to write about the exercise and its effects. Next, an MI section will outline specific MI-based topics (e.g., pros/cons, managing slips) and facilitate physical activity goal-setting. Following randomization, participants will engage in weekly, 30-minute phone calls over the next 8 weeks. Participants will independently complete PP exercises and MI-based goals between phone sessions and review them during phone sessions. PP and MI components will be delivered step-wise within sessions (rather than intertwined).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MI-based Health Education Intervention
Description: Each week, participants will learn about a different health behavior topic related to diabetes health. As an attentional control, this condition has a parallel structure to the experimental arm with a treatment manual, weekly assignments, and weekly calls to review assignments. Motivational interviewing topics (e.g., pros and cons of behavior change, importance and confidence of behavior change, identification of barriers and resources to change) will be presented related to each health behavior.
Study: NCT01351922

Intervention type: OTHER
Intervention: No treatment given
Description: Patients will fill out a questionaire by interview.
Study: NCT03472183

Intervention type: OTHER
Group type: OTHER
Intervention: biopsies of colon
Description: Removal of additional biopsies of colon during the course of a colonoscopy planned for usual medical follow-up of patient
Study: NCT01770756

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Care Training

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Care Training
Study: NCT03743376

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UB-421(25 mg/kg) Q2W
Description: Monoclonal antibody by IV infusion plus standard ART

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UB-421(25 mg/kg) Q4W
Description: Monoclonal antibody by IV infusion plus standard ART
Study: NCT00517413

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methoxy polyethylene glycol-epoetin beta [Mircera]
Description: 120, 200 or 360 micrograms sc or iv monthly, starting dose
Study: NCT04076618

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vest
Description: Weighted Vest worn \> or = 8 hours per day
Study: NCT03472183

Intervention type: OTHER
Group type: OTHER
Intervention: biopsies of colon
Description: Removal of additional biopsies of colon during the course of a colonoscopy planned for usual medical follow-up of patient

Intervention type: OTHER
Group type: OTHER
Intervention: biopsies of colon
Description: Removal of additional biopsies of colon during the course of a colonoscopy planned for usual medical follow-up of patient
Study: NCT01881360

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gluten-free diet
Description: A diet that is free of the gluten component

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hypocaloric diet
Description: A standard hypocaloric diet with a daily 1500 caloric intake.
Study: NCT02643680

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The novel biocellulose wound dressing
Description: The novel biocellulose dressing will used as a primary dressing at one half of the donor site. Then,the wound will be covered with 2 layers of gauze (secondary dressing) and 1 layer of bandage.The primary dressing will be unchanged until the wound healing (the day that the dressing detaches by itself with no exudate and air contacted pain) except signs of infection. The secondary dressing will be changed when excessive fluid appears.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bactigras
Description: Bactigras will used as a primary dressing at another one half of the donor site. Then,the wound will be covered with 2 layers of gauze (secondary dressing) and 1 layer of bandage.The primary dressing will be unchanged until the wound healing (the day that the dressing detaches by itself with no exudate and air contacted pain) except signs of infection. The secondary dressing will be changed when excessive fluid appears.
Study: NCT03678129

Intervention type: DRUG
Group type: OTHER
Intervention: AZD7325_10
Description: Single oral dose (10mg)

Intervention type: DRUG
Group type: OTHER
Intervention: AZD7325_20
Description: Single oral dose (20mg)

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Single oral dose placebo (capsule)
Study: NCT04076618

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Resistance Exercise Training
Description: Structured exercise training 3 days a week

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: weight loss program
Description: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: weight loss program
Description: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: weight loss program
Description: a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)
Study: NCT04019392

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Game Ready® device
Description: The half leg boot sleeve of the Game Ready® device (CoolSystems, Inc., Alamda, CA) will be applied to each participants' lower leg and ankle for 30 minutes set on the medium pressure setting (5-50 mmHG).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Wetted Ice Bag with Elastic Wrap
Description: A standard ice bag filled with 2000 mL of cubed ice and 300 mL of 5˚C water will be applied using an elastic wrap to each participants' lower leg for 30 minutes. An elastic wrap applied at approximately 75% percent tension starting distal to the treatment area and moving proximally overlapping by half will be applied over the wetted ice bag.
Study: NCT02615262

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% Sodium Chloride
Study: NCT02049788

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: low calorie/fat diet
Description: Conventional behavioural lifestyle modification instructions x 1/month for 6 months about low-calorie (approximately 1200-1300 kcal/day), low-fat (25% of total calories from fat) and about physical activity (increase non-weight bearing exercise 30 minutes/day at least x 3 times/week, increase physical activity in their routine and decrease sedentary activity).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low glycaemic index diet
Description: Experimental behavioural lifestyle modification instructions x 1/month for 6 months about low glycaemic index diet (selection of low-GI carbohydrates with the caloric distribution of carbohydrate 50-55%: protein 15-20%: fat 30-35%, instruction by two-hour small classes with parental participation low GI cooking demonstration and food labeling guidance) and about physical activity (increase non-weight bearing exercise 30 minutes/day at least x 3/week, increase physical activity in their routine and decrease sedentary activity).
Study: NCT03678129

Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Single oral dose placebo (capsule)

Intervention type: DRUG
Group type: OTHER
Intervention: Clobazam
Description: Single dose (5mg)
Study: NCT01352910

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rTMS
Description: 120 pulses 0.2 Hz

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS
Description: 120 pulses 0.2 Hz
Study: NCT02517567

Intervention type: DEVICE
Group type: OTHER
Intervention: Delefilcon A contact lenses
Description: Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Intervention type: DEVICE
Group type: OTHER
Intervention: Delefilcon A contact lenses
Description: Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Intervention type: DEVICE
Group type: OTHER
Intervention: Delefilcon A contact lenses
Description: Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Intervention type: DEVICE
Group type: OTHER
Intervention: Delefilcon A contact lenses
Description: Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Intervention type: DEVICE
Group type: OTHER
Intervention: Narafilcon A contact lenses
Description: Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Intervention type: DEVICE
Group type: OTHER
Intervention: Narafilcon A contact lenses
Description: Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Intervention type: DEVICE
Group type: OTHER
Intervention: Narafilcon A contact lenses
Description: Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Intervention type: DEVICE
Group type: OTHER
Intervention: Narafilcon A contact lenses
Description: Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Intervention type: DEVICE
Group type: OTHER
Intervention: Somofilcon A contact lenses
Description: Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Intervention type: DEVICE
Group type: OTHER
Intervention: Somofilcon A contact lenses
Description: Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Intervention type: DEVICE
Group type: OTHER
Intervention: Somofilcon A contact lenses
Description: Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Intervention type: DEVICE
Group type: OTHER
Intervention: Somofilcon A contact lenses
Description: Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions
Study: NCT01699906

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet regimen to induce weight loss
Description: Diet regimen to induce weight loss
Study: NCT05108155

Intervention type: PROCEDURE
Intervention: Cemented THA
Description: THA with cement fixation

Intervention type: PROCEDURE
Intervention: Unemented THA
Description: THA with uncemented / pressfit fixation
Study: NCT05384093

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High Intensity Stretch Device
Description: High Intensity Stretch and Physical Therapy are used either together or alone to treat study arm.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High Intensity Stretch Device
Description: High Intensity Stretch and Physical Therapy are used either together or alone to treat study arm.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High Intensity Stretch Device
Description: High Intensity Stretch and Physical Therapy are used either together or alone to treat study arm.
Study: NCT00006237

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: interleukin-2
Description: Given IV
Study: NCT04445051

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SpeediCath® Standard male or female
Description: Intermittent catheterization through the urethra draining the bladder, using SpeediCath® Standard male or female.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: New intermittent Variant 1 catheter for male or female
Description: Intermittent catheterization through the urethra draining the bladder, using the new Variant 1 for male or female.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: New intermittent Variant 2 catheter for male or female
Description: Intermittent catheterization through the urethra draining the bladder, using the new Variant 2 for male or female.
Study: NCT01506219

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Geriatrician-performed CGC
Description: Individual disease management and coping was provided using the holistic approach during the face-to-face counselling, where the actual problems, expectations and aims were defined in dialogue with the patient and/or relatives. Afterwards, targeted problem solving with focus on the potentially reversible causes of functional deterioration was established. Finally, medication adjustment was carried out with particular attention to drugs which may lead to iatrogenic functional deterioration, delirium, falls, and malnutrition. Furthermore, the intervention included intravenous antibiotics or blood transfusions (if indicated) conducted by the geriatrician at the rehabilitation units.
Study: NCT00479349

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SAM-531
Description: Multiple ascending doses of SAM 531: 1,5; 3 and 5 mg.
Study: NCT01949857

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Attenuated HAV Vaccine, H2 Strain
Description: 6.50 lgCCID50/Vial in babies aged 18-35 months\\6.50 lgCCID50/Vial in children aged 3-15 years \\6.50 lgCCID50/Vial in adults aged 16 up to 65 years old, only one dose (1Vial/dose).

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Attenuated HAV Vaccine, L-A-1 Strain
Description: 6.50 lgCCID50/Vial in babies aged 18-35 months\\6.50 lgCCID50/Vial in children aged 3-15 years \\6.50 lgCCID50/Vial in adults aged 16 up to 65 years old, only one dose (1Vial/dose).

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated HAV Vaccine, Lu8 Strain
Description: 320EU/Vial in babies aged 18-35 months\\320EU/Vial in children aged 3-15 years \\640EU/Vial in adults aged 16 up to 65 years old\\boost at month 6\\two-dose

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated HAV Vaccine, TZ84 Strain
Description: 250U/Vial in babies aged 18-35 months\\250U/Vial in children aged 3-15 years \\500U/Vial in adults aged 16 up to 65 years old\\boost at month 6\\two-dose.